ID   FCGR2_MOUSE             Reviewed;         330 AA.
AC   P08101; P08102; P12316; P97917; Q60938; Q60939; Q60940; Q61170; Q61558;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   07-APR-2021, entry version 187.
DE   RecName: Full=Low affinity immunoglobulin gamma Fc region receptor II;
DE   AltName: Full=Fc gamma receptor IIB;
DE            Short=Fc-gamma RII;
DE            Short=Fc-gamma-RIIB;
DE            Short=FcRII;
DE   AltName: Full=IgG Fc receptor II beta;
DE   AltName: Full=Lymphocyte antigen 17;
DE            Short=Ly-17;
DE   AltName: CD_antigen=CD32;
DE   Flags: Precursor;
GN   Name=Fcgr2; Synonyms=Fcgr2b, Ly-17;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 30-51 (ISOFORMS IIB1
RP   AND IIB2).
RX   PubMed=2946078; DOI=10.1126/science.2946078;
RA   Ravetch J.V., Luster A.D., Weinshank R., Kochan J., Pavlovec A.,
RA   Portnoy D.A., Hulmes J., Pan Y.-C.E., Unkeless J.C.;
RT   "Structural heterogeneity and functional domains of murine immunoglobulin G
RT   Fc receptors.";
RL   Science 234:718-725(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IIB2).
RC   TISSUE=Macrophage;
RX   PubMed=3024012; DOI=10.1038/324372a0;
RA   Lewis V.A., Koch T., Plutner H., Mellman I.;
RT   "A complementary DNA clone for a macrophage-lymphocyte Fc receptor.";
RL   Nature 324:372-375(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE (ISOFORM IIB1).
RX   PubMed=2957319; DOI=10.1007/bf00365906;
RA   Hogarth P.M., Hibbs M.L., Bonadonna L., Scott B.M., Witort E.,
RA   Pietersz G.A., McKenzie I.F.C.;
RT   "The mouse Fc receptor for IgG (Ly-17): molecular cloning and
RT   specificity.";
RL   Immunogenetics 26:161-168(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM IIB1), POLYMORPHISM, AND
RP   VARIANTS.
RC   STRAIN=BALB/cJ; TISSUE=Spleen;
RX   PubMed=2138587; DOI=10.1007/bf00211557;
RA   Lah M., Quelch K., Deacon N.J., McKenzie I.F., Hogarth P.M.;
RT   "Identification of the mouse beta Fc gamma RII polymorphism by direct
RT   sequencing of amplified genomic DNA.";
RL   Immunogenetics 31:202-206(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS IIB1 AND IIB2).
RX   PubMed=1824594;
RA   Hogarth P.M., Witort E., Hulett M.D., Bonnerot C., Even J., Fridman W.H.,
RA   McKenzie I.F.C.;
RT   "Structure of the mouse beta Fc gamma receptor II gene.";
RL   J. Immunol. 146:369-376(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IIB1').
RC   STRAIN=DBA/2J; TISSUE=Mast cell;
RX   PubMed=8683114;
RA   Latour S., Fridman W.H., Daeron M.;
RT   "Identification, molecular cloning, biologic properties, and tissue
RT   distribution of a novel isoform of murine low-affinity IgG receptor
RT   homologous to human Fc gamma RIIB1.";
RL   J. Immunol. 157:189-197(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-330 (ISOFORMS IIB1 AND IIB2).
RC   STRAIN=DBA/2J, and NZB; TISSUE=Spleen;
RX   PubMed=8537115; DOI=10.1007/bf00186618;
RA   Sawchuk D.J., Mahmoudi M., Cairns E., Sinclair N.R.S.;
RT   "Nonsynonymous mutations in an Fc-receptor structural gene in NZB mice.";
RL   Immunogenetics 43:112-113(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 17-45.
RX   PubMed=2944118; DOI=10.1073/pnas.83.18.6980;
RA   Hibbs M.L., Walker I.D., Kirszbaum L., Peitersz G.A., Deacon N.J.,
RA   Chambers G.W., McKenzie I.F.C., Hogarth P.M.;
RT   "The murine Fc receptor for immunoglobulin: purification, partial amino
RT   acid sequence, and isolation of cDNA clones.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6980-6984(1986).
RN   [9]
RP   CHARACTERIZATION OF ISOFORM IIB3.
RC   TISSUE=Macrophage;
RX   PubMed=8398981; DOI=10.1093/intimm/5.8.859;
RA   Tartour E., de la Salle H., de la Salle C., Teillaud C., Camoin L.,
RA   Galinha A., Latour S., Hanau D., Fridman W.H., Sautes C.;
RT   "Identification, in mouse macrophages and in serum, of a soluble receptor
RT   for the Fc portion of IgG (Fc gamma R) encoded by an alternatively spliced
RT   transcript of the Fc gamma RII gene.";
RL   Int. Immunol. 5:859-868(1993).
RN   [10]
RP   PHOSPHORYLATION, AND INTERACTION WITH LYN.
RX   PubMed=9469421;
RA   Malbec O., Fong D.C., Turner M., Tybulewicz V.L., Cambier J.C.,
RA   Fridman W.H., Daeron M.;
RT   "Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma
RT   receptor IIB during negative regulation of mast cell activation.";
RL   J. Immunol. 160:1647-1658(1998).
RN   [11]
RP   PHOSPHORYLATION AT TYR-290; TYR-309 AND TYR-326.
RX   PubMed=11035084; DOI=10.4049/jimmunol.165.8.4453;
RA   Fong D.C., Brauweiler A., Minskoff S.A., Bruhns P., Tamir I., Mellman I.,
RA   Daeron M., Cambier J.C.;
RT   "Mutational analysis reveals multiple distinct sites within Fc gamma
RT   receptor IIB that function in inhibitory signaling.";
RL   J. Immunol. 165:4453-4462(2000).
CC   -!- FUNCTION: Receptor for the Fc region of complexed immunoglobulins
CC       gamma. Low affinity receptor. Involved in a variety of effector and
CC       regulatory functions such as phagocytosis of antigen-antibody complexes
CC       from the circulation and modulation of antibody production by B-cells.
CC       Isoform IIB1 and isoform IIB1' form caps but fail to mediate
CC       endocytosis or phagocytosis. Isoform IIB2 can mediate the endocytosis
CC       of soluble immune complexes via clathrin-coated pits. Isoform IIB1 and
CC       isoform IIB2 can down-regulate B-cell, T-cell, and mast cell activation
CC       when coaggregated to B-cell receptors for AG (BCR), T-cell receptors
CC       for AG (TCR), and Fc receptors, respectively.
CC   -!- SUBUNIT: Interacts with FGR (By similarity). Interacts with LYN.
CC       {ECO:0000250, ECO:0000269|PubMed:9469421}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform IIB1]: Cytoplasm, cytoskeleton.
CC       Note=Binds the cytoskeleton and is not localized in endocytotic pits.
CC   -!- SUBCELLULAR LOCATION: [Isoform IIB3]: Secreted. Note=Released as a
CC       soluble molecule.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=IIB1; Synonyms=Beta-1;
CC         IsoId=P08101-1; Sequence=Displayed;
CC       Name=IIB2; Synonyms=Beta-2;
CC         IsoId=P08101-2; Sequence=VSP_002640;
CC       Name=IIB1'; Synonyms=Beta-1';
CC         IsoId=P08101-3; Sequence=VSP_002641;
CC       Name=IIB3; Synonyms=Beta-3;
CC         IsoId=P08101-4; Sequence=Not described;
CC   -!- TISSUE SPECIFICITY: Widely expressed by cells of hemopoietic origin.
CC       The isoforms are differentially expressed. Isoform IIB1 is
CC       preferentially expressed by cells of the lymphoid lineage, isoform IIB2
CC       by cells of the myeloid lineage, and isoform IIB3 is released by
CC       macrophages and is present in the serum. Isoform IIB1' is expressed in
CC       myeloid and lymphoid cell lines, in normal spleen cells, and in resting
CC       or LPS-activated B-cells but is not detected in mesenteric lymph node
CC       cells.
CC   -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC       Another tyrosine-containing sequence, more C-terminal, accounts for the
CC       ability of isoform IIB2 to trigger the phagocytosis of particulate
CC       immuno complexes.
CC   -!- PTM: Glycosylated.
CC   -!- PTM: When coaggregated to BCR, isoform IIB1 and isoform IIB1' become
CC       tyrosine phosphorylated and bind to the SH2 domains of the protein
CC       tyrosine phosphatase PTPC1. Phosphorylated by SRC-type Tyr-kinases such
CC       as LYN, BLK, FYN and SYK (By similarity). {ECO:0000250}.
CC   -!- POLYMORPHISM: Ly-17 alloantigenic system involves residues 116 and 161.
CC       Ly-17.1 mice are Pro-116 and Glu-161; Ly-17.2 mice are Leu-116 and Leu-
CC       161. These polymorphisms do not affect IgG binding.
CC       {ECO:0000269|PubMed:2138587}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA28309.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M16367; AAA37608.1; -; mRNA.
DR   EMBL; M14216; AAA37609.1; -; mRNA.
DR   EMBL; M17515; AAA37607.1; -; mRNA.
DR   EMBL; M31312; AAA37610.1; -; Genomic_DNA.
DR   EMBL; X04648; CAA28309.1; ALT_INIT; mRNA.
DR   EMBL; U31801; AAA92707.1; -; mRNA.
DR   EMBL; U31802; AAA92708.1; -; mRNA.
DR   EMBL; U31803; AAA92709.1; -; mRNA.
DR   EMBL; U31804; AAA92710.1; -; mRNA.
DR   EMBL; M14276; AAA37605.1; -; mRNA.
DR   EMBL; U51629; AAA97464.1; -; mRNA.
DR   PIR; A40071; A40071.
DR   PIR; B40071; FCMSG1.
DR   PIR; I49660; I49660.
DR   RefSeq; NP_034317.1; NM_010187.2.
DR   SMR; P08101; -.
DR   BioGRID; 199619; 3.
DR   ELM; P08101; -.
DR   IntAct; P08101; 1.
DR   MINT; P08101; -.
DR   STRING; 10090.ENSMUSP00000027966; -.
DR   MEROPS; I43.001; -.
DR   GlyConnect; 342; 18 N-Linked glycans.
DR   GlyGen; P08101; 4 sites.
DR   iPTMnet; P08101; -.
DR   PhosphoSitePlus; P08101; -.
DR   jPOST; P08101; -.
DR   PaxDb; P08101; -.
DR   PRIDE; P08101; -.
DR   ProteomicsDB; 272973; -. [P08101-1]
DR   ProteomicsDB; 272974; -. [P08101-2]
DR   ProteomicsDB; 272975; -. [P08101-3]
DR   GeneID; 14130; -.
DR   KEGG; mmu:14130; -.
DR   UCSC; uc007dms.2; mouse. [P08101-1]
DR   UCSC; uc007dmt.2; mouse. [P08101-2]
DR   CTD; 2213; -.
DR   MGI; MGI:95499; Fcgr2b.
DR   eggNOG; ENOG502SVEW; Eukaryota.
DR   InParanoid; P08101; -.
DR   PhylomeDB; P08101; -.
DR   Reactome; R-MMU-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-MMU-2029481; FCGR activation.
DR   Reactome; R-MMU-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-MMU-2029485; Role of phospholipids in phagocytosis.
DR   Reactome; R-MMU-6798695; Neutrophil degranulation.
DR   BioGRID-ORCS; 14130; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Fcgr2b; mouse.
DR   PRO; PR:P08101; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; P08101; protein.
DR   GO; GO:0044297; C:cell body; IDA:ARUK-UCL.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0043197; C:dendritic spine; IDA:ARUK-UCL.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IDA:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:MGI.
DR   GO; GO:0045121; C:membrane raft; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0055037; C:recycling endosome; ISO:MGI.
DR   GO; GO:0001540; F:amyloid-beta binding; ISO:MGI.
DR   GO; GO:0019864; F:IgG binding; IDA:MGI.
DR   GO; GO:0019865; F:immunoglobulin binding; ISO:MGI.
DR   GO; GO:0019772; F:low-affinity IgG receptor activity; ISO:MGI.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; IMP:MGI.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IMP:MGI.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IMP:ARUK-UCL.
DR   GO; GO:0071219; P:cellular response to molecule of bacterial origin; IMP:MGI.
DR   GO; GO:0021549; P:cerebellum development; IMP:ARUK-UCL.
DR   GO; GO:0006952; P:defense response; IMP:MGI.
DR   GO; GO:0016358; P:dendrite development; IMP:ARUK-UCL.
DR   GO; GO:0032456; P:endocytic recycling; ISO:MGI.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; ISO:MGI.
DR   GO; GO:0002434; P:immune complex clearance; ISO:MGI.
DR   GO; GO:0016064; P:immunoglobulin mediated immune response; IMP:MGI.
DR   GO; GO:0002865; P:negative regulation of acute inflammatory response to antigenic stimulus; IMP:MGI.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; IMP:MGI.
DR   GO; GO:0050859; P:negative regulation of B cell receptor signaling pathway; ISO:MGI.
DR   GO; GO:0002924; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; IMP:MGI.
DR   GO; GO:0050777; P:negative regulation of immune response; IMP:MGI.
DR   GO; GO:0002638; P:negative regulation of immunoglobulin production; IMP:MGI.
DR   GO; GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; IMP:MGI.
DR   GO; GO:0032693; P:negative regulation of interleukin-10 production; IMP:MGI.
DR   GO; GO:0033030; P:negative regulation of neutrophil apoptotic process; ISO:MGI.
DR   GO; GO:0050765; P:negative regulation of phagocytosis; IMP:MGI.
DR   GO; GO:0001811; P:negative regulation of type I hypersensitivity; IMP:MGI.
DR   GO; GO:0006911; P:phagocytosis, engulfment; IDA:MGI.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IMP:ARUK-UCL.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IMP:ARUK-UCL.
DR   GO; GO:1901216; P:positive regulation of neuron death; IMP:ARUK-UCL.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IDA:MGI.
DR   GO; GO:1905898; P:positive regulation of response to endoplasmic reticulum stress; IMP:ARUK-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISO:MGI.
DR   GO; GO:1902950; P:regulation of dendritic spine maintenance; IMP:ARUK-UCL.
DR   GO; GO:0050776; P:regulation of immune response; IBA:GO_Central.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IMP:ARUK-UCL.
DR   GO; GO:0009617; P:response to bacterium; IMP:MGI.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   Pfam; PF13895; Ig_2; 2.
DR   SMART; SM00409; IG; 2.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   IgG-binding protein; Immunoglobulin domain; Membrane; Phosphoprotein;
KW   Receptor; Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..29
FT   CHAIN           30..330
FT                   /note="Low affinity immunoglobulin gamma Fc region receptor
FT                   II"
FT                   /id="PRO_0000015143"
FT   TOPO_DOM        30..210
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        211..231
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        232..330
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          50..106
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          131..189
FT                   /note="Ig-like C2-type 2"
FT   MOTIF           307..312
FT                   /note="ITIM motif"
FT   MOD_RES         290
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:11035084"
FT   MOD_RES         309
FT                   /note="Phosphotyrosine; by SRC-type Tyr-kinases"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         326
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:11035084"
FT   CARBOHYD        65
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        92
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        166
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        173
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        57..99
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        138..182
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         243..290
FT                   /note="ALPGNPDHREMGETLPEEVGEYRQPSGGSVPVSPGPPSGLEPTSSSPY ->
FT                   D (in isoform IIB2)"
FT                   /evidence="ECO:0000303|PubMed:3024012,
FT                   ECO:0000303|PubMed:8537115"
FT                   /id="VSP_002640"
FT   VAR_SEQ         262..290
FT                   /note="GEYRQPSGGSVPVSPGPPSGLEPTSSSPY -> D (in isoform
FT                   IIB1')"
FT                   /evidence="ECO:0000303|PubMed:8683114"
FT                   /id="VSP_002641"
FT   VARIANT         116
FT                   /note="S -> L (in strain: DBA/2; Ly17.2 allotype)"
FT                   /evidence="ECO:0000269|PubMed:2138587"
FT   VARIANT         116
FT                   /note="S -> P (in strain: NZB; Ly17.1 allotype)"
FT                   /evidence="ECO:0000269|PubMed:2138587"
FT   VARIANT         145
FT                   /note="L -> P"
FT   VARIANT         161
FT                   /note="H -> L (in strain: DBA/2; Ly17.2 allotype)"
FT                   /evidence="ECO:0000269|PubMed:2138587"
FT   VARIANT         161
FT                   /note="H -> Q (in strain: NZB; Ly17.1 allotype)"
FT                   /evidence="ECO:0000269|PubMed:2138587"
FT   VARIANT         190
FT                   /note="L -> Q"
FT   VARIANT         195
FT                   /note="P -> T (in strain: NZB)"
FT   VARIANT         287
FT                   /note="S -> I (in strain: NZB)"
FT   CONFLICT        270..278
FT                   /note="GSVPVSPGP -> LSACQPRA (in Ref. 1; AAA37608)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        299
FT                   /note="A -> P (in Ref. 3 and 4)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   330 AA;  36695 MW;  A463B9EFF2717511 CRC64;
     MESNWTVHVF SRTLCHMLLW TAVLNLAAGT HDLPKAVVKL EPPWIQVLKE DTVTLTCEGT
     HNPGNSSTQW FHNGRSIRSQ VQASYTFKAT VNDSGEYRCQ MEQTRLSDPV DLGVISDWLL
     LQTPQLVFLE GETITLRCHS WRNKLLNRIS FFHNEKSVRY HHYSSNFSIP KANHSHSGDY
     YCKGSLGRTL HQSKPVTITV QGPKSSRSLP VLTIVAAVTG IAVAAIVIIL VSLVYLKKKQ
     VPALPGNPDH REMGETLPEE VGEYRQPSGG SVPVSPGPPS GLEPTSSSPY NPPDLEEAAK
     TEAENTITYS LLKHPEALDE ETEHDYQNHI
//
